SEC Form 4 · accession 0001140361-17-023437
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 11:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | holding | — | — | — | 78,112 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $71.89 | Jun 1, 2017 | A | 6,982 | A | Jun 1, 2018 | Jun 1, 2024 | ResMed Common Stock | 6,982 | 6,982 | D |
Explanation of responses
- F1Includes 216 shares of ResMed stock purchased on April 28, 2017, through the ResMed Employee Stock Purchase Plan.
- F2Represents date options first become exercisable. Options vest 1/3 annually each June 1, 2018, 2019 and 2020.